Another study on ovarian cancer models [133], evidenced that PCSK9 is also upregulated in ovarian cancer cells and correlated with tumor invasiveness by direct stimulation of ERK/MEK pathways. This evidence concerns the gene MAP2K7 and ovarian carcinoma.